Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Pavel N. Lizhnyak"'
Publikováno v:
BMC Public Health, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Background Electronic cigarettes (e-cigarettes) have become the most common tobacco product used among adolescents in the United States (US). Prior research has shown that peer e-cigarette use was associated with increased risk of own e-ciga
Externí odkaz:
https://doaj.org/article/69eb196201ff4988a909c2ba0af20674
Autor:
Pavel N. Lizhnyak, Brendan Noggle, Lai Wei, Jeffery Edmiston, Elizabeth Becker, Ryan A. Black, Mohamadi Sarkar
Publikováno v:
Harm Reduction Journal, Vol 19, Iss 1, Pp 1-10 (2022)
Abstract Introduction People who both smoke cigarettes and vape are often considered as a homogenous group even though multiple subgroups may exist. We examined biomarkers of exposure (BOE) and biomarkers of potential harm (BOPH) to differentiate bet
Externí odkaz:
https://doaj.org/article/6d35f4c0ebfc461b9cc0eb0b64b45e16
Publikováno v:
BMC Public Health, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background Susceptibility to tobacco use predicts tobacco use onset among youth. The current study aimed to estimate the extent of overlap in susceptibilities across various tobacco products, investigate sociopsychological correlates with su
Externí odkaz:
https://doaj.org/article/18f1cb09491645fda7c6d65addb1a487
Autor:
Jeffery Edmiston, Ryan A. Black, Richard B. Noggle, Lai Wei, Elizabeth Becker, Mohamadi Sarkar, Pavel N. Lizhnyak
Introduction: Dual users of cigarettes and e-vapor products (EVP) are often considered as a homogenous group even though multiple subgroups may exist. We examined biomarkers of exposure (BOE) and biomarkers of potential harm (BOPH) to differentiate b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df61daf2c3fab5438d444c9c14bcb1a6
https://doi.org/10.21203/rs.3.rs-922547/v1
https://doi.org/10.21203/rs.3.rs-922547/v1
Publikováno v:
J Neurotrauma
Advancing therapeutics for traumatic brain injury (TBI) remains a challenge, necessitating testable targets with interventions appropriately timed to intercede on evolving secondary insults. Neuroproteomics provides a global molecular approach to ded
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d1da0e81bdc3b81d90f3de33a27e951
https://pubmed.ncbi.nlm.nih.gov/31122143
https://pubmed.ncbi.nlm.nih.gov/31122143
Autor:
Andrew K. Ottens, Pavel N Lizhnyak
Effective traumatic brain injury (TBI) therapeutics remains stubbornly elusive. Efforts in the field have been challenged by the heterogeneity of clinical TBI, with greater complexity among underlying molecular phenotypes than initially conceived. Fu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6cefe9b8a737aa6585ac036be9228d1
https://europepmc.org/articles/PMC4664524/
https://europepmc.org/articles/PMC4664524/